BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 29748184)

  • 21. miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.
    Adams BD; Wali VB; Cheng CJ; Inukai S; Booth CJ; Agarwal S; Rimm DL; Győrffy B; Santarpia L; Pusztai L; Saltzman WM; Slack FJ
    Cancer Res; 2016 Feb; 76(4):927-39. PubMed ID: 26676753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
    Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
    Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer.
    Gu Y; Wang W; Wang X; Xie H; Ye X; Shu P
    Sci Rep; 2019 Sep; 9(1):13830. PubMed ID: 31554904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
    Sun M; Wang X; Tu C; Wang S; Qu J; Xiao S
    Cell Biol Int; 2017 Dec; 41(12):1272-1282. PubMed ID: 28225180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells.
    Hamurcu Z; Delibaşı N; Nalbantoglu U; Sener EF; Nurdinov N; Tascı B; Taheri S; Özkul Y; Donmez-Altuntas H; Canatan H; Ozpolat B
    J Mol Med (Berl); 2019 Apr; 97(4):491-508. PubMed ID: 30729279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple-negative breast cancer.
    Yang N; Wang C; Wang J; Wang Z; Huang D; Yan M; Kamran M; Liu Q; Xu B
    J Cell Mol Med; 2019 Sep; 23(9):6442-6453. PubMed ID: 31359594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1.
    Yi J; Li H; Chu B; Kon N; Hu X; Hu J; Xiong Y; Kaniskan HU; Jin J; Gu W
    Cell Death Differ; 2023 Jul; 30(7):1799-1810. PubMed ID: 37291217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric Adenocarcinoma Predictive Long Intergenic Non-Coding RNA Promotes Tumor Occurrence and Progression in Non-Small Cell Lung Cancer via Regulation of the miR-661/eEF2K Signaling Pathway.
    Gu H; Chen J; Song Y; Shao H
    Cell Physiol Biochem; 2018; 51(5):2136-2147. PubMed ID: 30522114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
    Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression.
    Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q
    Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration.
    Song GQ; Zhao Y
    Tumour Biol; 2015 Jul; 36(7):5001-9. PubMed ID: 25680404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.
    Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C
    Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
    Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
    J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
    Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
    BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.